Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. PHVS
9. QQQ
10. UNFI

Go back to Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.96 -0.23 (2.26%)
Previous Close $10.19    52 Week High $9.23 
Open $10.02    52 Week Low $1.16 
Day High $10.24    P/E N/A 
Day Low $9.85    EPS $-0.30 
Volume 557,943